DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE.
The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
Headache 2010;
50 (06) 1089-99.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.